 |
|
Rapport(s) public(s) d'évaluation ansm (RAPPE) et EMEA (EPAR)
| NOVOSEVEN (EPAR) 2022 |
Recommandations et protocoles thérapeutiques ansm, HAS, INCa
| PNDS 2019 - THROMBASTHENIE GLANZMANN | |
| PNDS 2019 - HEMOPHILIE | |
| NOVOSEVEN RTU 2017 | |
| PNDS 2013 - THROMBASTHENIE GLANZMANN | |
| NOVOSEVEN CONDITIONS D'UTILISATION | |
| NOVOSEVEN 2008 (PTT 1) | |
| NOVOSEVEN 2008 (PTT 2) | |
| NOVOSEVEN 2008 (PTT 3) | |
| NOVOSEVEN 2008 (HORS AMM - SANS DONNEES) |
Page générée en 0.0286 seconde(s)